Table of Content


Chapter 1   Methodology & Scope
1.1    Market scope & definitions
1.2    Research design
1.2.1    Research approach
1.2.2    Data collection methods
1.3    Base estimates & calculations
1.3.1    Base year calculation
1.3.2    Key trends for market estimation
1.4    Forecast model
1.5    Primary research and validation
1.5.1    Primary sources
1.5.2    Data mining sources
Chapter 2   Executive Summary
2.1    Industry 360? Synopsis
Chapter 3   Industry Insights
3.1    Industry ecosystem analysis
3.2    Industry impact forces
3.2.1    Growth drivers
3.2.1.1    Increasing volume of surgical procedures
3.2.1.2    Advancements in anesthesia technology
3.2.2    Industry pitfalls & challenges
3.2.2.1    Adverse effects and safety concerns
3.2.2.2    Regulatory and compliance challenges
3.3    Growth potential analysis
3.4    Regulatory landscape
3.5    Technological landscape
3.6    Future market trends
3.7    Gap analysis
3.8    Porter’s analysis
3.9    PESTEL analysis
Chapter 4   Competitive Landscape, 2024
4.1    Introduction
4.2    Company market share analysis
4.3    Company matrix analysis
4.4    Competitive analysis of major market players
4.5    Competitive positioning matrix
4.6    Strategy dashboard
Chapter 5   Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)
5.1    Key trends
5.2    Sevoflurane
5.3    Propofol
5.4    Dexmedetomidine
5.5    Remifentanil
5.6    Desflurane
5.7    Midazolam
5.8    Ketamine
5.9    Other drugs
Chapter 6   Market Estimates and Forecast, By Route of Administration, 2021 – 2034 ($ Mn)
6.1    Key trends
6.2    Intravenous
6.3    Inhalational
Chapter 7   Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)
7.1    Key trends
7.2    Neurological surgery
7.3    Cardiovascular surgery
7.4    Orthopedic surgery
7.5    Other applications
Chapter 8   Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)
8.1    Key trends
8.2    Hospitals
8.3    Ambulatory surgical centers
8.4    Specialty clinics
Chapter 9   Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
9.1    Key trends
9.2    North America
9.2.1    U.S.
9.2.2    Canada
9.3    Europe
9.3.1    Germany
9.3.2    UK
9.3.3    France
9.3.4    Spain
9.3.5    Italy
9.3.6    Netherlands
9.4    Asia Pacific
9.4.1    China
9.4.2    Japan
9.4.3    India
9.4.4    Australia
9.4.5    South Korea
9.5    Latin America
9.5.1    Brazil
9.5.2    Mexico
9.5.3    Argentina
9.6    Middle East and Africa
9.6.1    South Africa
9.6.2    Saudi Arabia
9.6.3    UAE
Chapter 10   Company Profiles
10.1    Abbott Laboratories
10.2    AbbVie
10.3    AstraZeneca plc
10.4    B. Braun Melsungen AG
10.5    Baxter International Inc.
10.6    Eisai Co.
10.7    Fresenius SE & Co. KGaA
10.8    Hikma Pharmaceuticals
10.9    Hikma Pharmaceuticals
10.10    Novartis AG
10.11    Par Pharmaceutical
10.12    Pfizer
10.13    Piramal Critical Care
10.14    Teva Pharmaceutical Industries
10.15    Viatris